Beijing Strong Biotechnologies,Inc. (SHE:300406)

Market Cap	7.39B -6.5%
Revenue (ttm)	1.37B -4.1%
Net Income	250.64M -42.7%
EPS	0.43 -41.7%
Shares Out	584.78M
PE Ratio	29.63
Forward PE	17.55
Dividend	0.70 (5.54%)
Ex-Dividend Date	Sep 3, 2026

Volume	9,348,993
Open	12.58
Previous Close	12.46
Day's Range	12.39 - 12.69
52-Week Range	10.52 - 16.05
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHE:300406

Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. It provides biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein S activity, protein C, lu...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2001
• Employees: 998
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300406

Financial Performance

In 2025, SHE:300406's revenue was 1.36 billion, a decrease of -18.29% compared to the previous year's 1.66 billion. Earnings were 189.87 million, a decrease of -64.73%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 2, 2026

Data Sources Report a data error